GMI on the Dexcom G7 stands for Glucose Management Indicator. It is a CGM-derived estimate of what your A1C would be based on the last 14 days of sensor readings, shown in the Dexcom G7 app alongside your average glucose and time-in-range. The formula, GMI (%) = 3.31 + 0.02392 × mean glucose in mg/dL, comes from a 2018 validation study by Bergenstal and colleagues.
Why GMI Exists
Lab A1C has been the standard for decades because it reflects average glucose over 2 to 3 months in a single blood draw. But A1C has drawbacks for the CGM era: it is slow to respond to change, it is affected by anemia and red cell turnover, and it cannot show whether time-in-range improved or worsened. GMI was designed to give a faster, more transparent number that works alongside A1C.
The Formula, in Plain English
GMI (%) = 3.31 + 0.02392 × mean glucose (mg/dL)
Examples:
- Mean glucose 120 mg/dL → GMI 6.2%
- Mean glucose 154 mg/dL → GMI 7.0%
- Mean glucose 183 mg/dL → GMI 7.7%
- Mean glucose 212 mg/dL → GMI 8.4%
The more time you spend in range, the closer GMI stays to your target. For a refresher on A1C itself, see our A1C levels hub.
Where GMI Appears in the Dexcom G7 App
- Statistics view: shows 14-day average, GMI, time-in-range bands, and standard deviation.
- Reports tab: the Ambulatory Glucose Profile (AGP) report includes GMI at the top.
- Clarity (Dexcom’s cloud software): clinicians see the same GMI and can compare it to your lab A1C during visits.
GMI vs A1C: What to Expect
| Feature | GMI | A1C |
|---|---|---|
| Measurement | CGM average over 14 days, converted by formula | Blood test reflecting red cell glycation over 2 to 3 months |
| Speed of response | Days | Weeks to months |
| Affected by anemia / hemolysis | No | Yes |
| Affected by CGM sensor drift | Yes | No |
| Good for | Tracking recent change, self-management | Long-term clinical trends, guideline-based targets |
| Expected agreement | Usually within 0.3 to 0.5 percentage points; larger gaps warrant investigation | |
Why GMI and A1C Sometimes Disagree
A consistent gap between the two numbers is not a defect; it is biology. Common reasons:
- Red cell turnover. If your cells live longer than average, they have more time to glycate, raising A1C for the same average glucose. Shorter-lived cells lower it.
- Hemoglobin variants. Sickle cell trait, HbC, HbE, and other variants can interfere with specific A1C assay methods.
- Iron deficiency. Raises A1C without a true glucose rise.
- Chronic kidney disease. Alters red cell lifespan in complex ways.
- Pregnancy. A1C often reads lower than GMI because of higher red cell turnover.
- Recent transfusion. Donor cells reset the A1C calculation for weeks.
If your GMI and A1C consistently differ by more than 0.5 percentage points in the same direction, mention it to your doctor.
How to Use GMI Day to Day
- Check GMI weekly to see whether the last 14 days are on or off track.
- Pair it with time-in-range (TIR) — the percentage of time between 70 and 180 mg/dL. The ADA target for most adults is at least 70 percent TIR.
- Note major changes — a new medication, a vacation, an illness — and see how GMI responds over the next two weeks.
- Do not use GMI to replace A1C at clinical visits, but bring the 14-day AGP report so your doctor has the context alongside your lab result.
- If GMI has drifted up in the last two weeks, look at meal responses, exercise timing, and sleep before changing medications.
Limitations
- GMI depends on adequate sensor wear — aim for at least 14 days with greater than 70 percent data capture.
- Short windows (7 days) are volatile; 30-day GMI smooths noise but reacts slower.
- GMI cannot correct for CGM sensor drift — if your sensor consistently reads high or low versus fingersticks, GMI will inherit that error.
- Some people have a persistent personal glycation gap that makes their lab A1C always higher or lower than GMI. This is real and does not mean either number is wrong.
Related CGM Metrics Worth Knowing
- Time-in-range (TIR): percent of time in 70 to 180 mg/dL. Primary target: ≥ 70% for most adults.
- Time-below-range (TBR): percent of time under 70 mg/dL. Target: ≤ 4%.
- Time-above-range (TAR): percent over 180 mg/dL. Target: ≤ 25%.
- Coefficient of variation (CV): glucose variability. Target: ≤ 36%.
- Mean glucose: 14-day average in mg/dL (or mmol/L).
These together tell a more complete story than GMI alone. The Dexcom G7 app and the AGP report display all of them. For broader context on diabetes technology, see our detection of prediabetes hub.
The Bottom Line
GMI on the Dexcom G7 is your 14-day CGM average translated into an A1C-equivalent number. It is a faster, CGM-native way to track recent glucose control and pairs well with time-in-range. Use it as a near-real-time progress indicator, verify big decisions with lab A1C, and talk to your doctor whenever GMI and A1C disagree by more than half a percentage point.
